Study of people with REM sleep behavior disorder who may develop Parkinson disease
Enrolls people with a sleep disorder linked to Parkinson-type brain diseases to prepare future trials.
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- Atlanta, Boston, Los Angeles, Minneapolis, Portland, Redwood City, Rochester, St Louis, and Sun City, United StatesSee the 9 sitesAlso in 1 other country, 1 site
- Trial code
- Registry title
- North American Prodromal Synucleinopathy Consortium
- Status
- Enrolling by invitation
- People taking part
- 500 people, planned
- Started
- 29 Aug 2018
- Planned end
- 31 Jul 2026
- Type of study
- Observational
- Record updated
- 6 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with idiopathic REM sleep behavior disorder (RBD), to prepare for a later trial of treatments that protect the nerves.
- Age
- 18 Years and older
- Sex
- All sexes can join.
- Disease stage
- Idiopathic REM sleep behavior disorder (no other known cause).
Main reasons for not taking part
- REM sleep behavior disorder caused by another condition (for example narcolepsy, dementia, Parkinson's Disease)
- Another neurological disorder
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Idiopathic REM sleep behavior disorder
Who cannot take part
- REM sleep behavior disorder secondary to another cause (ex: narcolepsy, dementia, Parkinson's Disease, etc)
- Other neurological disorder
Where in United States
Also in 1 other country, 1 site
- Emory UniversityAtlanta, United StatesEnrolling by invitation
- Massachusetts General HospitalBoston, United StatesEnrolling by invitation
- University of California, Los AngelesLos Angeles, United StatesEnrolling by invitation
- University of MinnesotaMinneapolis, United StatesEnrolling by invitation
- Portland VA Medical CenterPortland, United StatesEnrolling by invitation
- Stanford UniversityRedwood City, United StatesEnrolling by invitation
- Mayo ClinicRochester, United StatesEnrolling by invitation
- Washington UniversitySt Louis, United StatesEnrolling by invitation
- Banner Sun Health Research InstituteSun City, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- North American Prodromal Synucleinopathy Consortium
- Plain-language title
- Study of people with REM sleep behavior disorder who may develop Parkinson diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder: A Multicenter Study.Neurology(R) neuroimmunology & neuroinflammation, 2024
- Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder.Neurology, 2023
- Record updated
- 6 November 2024